Josef von Rickenbach

Mr. Josef H.
von Rickenbach is a Chairman at Zageno, Inc., a Chairman at Rein Therapeutics, Inc., a Managing Director at Stet Vision LLC, a Director-Health Policy & Management Executive at Harvard T.H.
Chan School of Public Health and a Senior Advisor at General Atlantic LP.
He is on the Board of Directors at Breton Capital Management LLC, Javara, Inc., New England Healthcare Institute, McLean HealthCare, Inc. and McLean Hospital, Inc. Mr. von Rickenbach was previously employed as an Independent Director by NextGen Acquisition Corp.
II, an Independent Director by NextGen Acquisition Corp., a President & Chief Executive Officer by Helio Vision, Inc., a Chairman by PAREXEL International Corp., and a Manager by Enseco Energy Services Corp.
He also served on the board at Association of Clinical Research Organizations and PAREXEL International Ltd. He received his undergraduate degree from Lucerne University of Applied Sciences & Arts and an MBA from Harvard Business School.